BOC Sciences Blog

Oligonucleotide Drug Development

Current Status and Prospects of Oligonucleotide Drug Development

As an important drug modality, the development of oligonucleotides will continue to expand in the coming years. Oligonucleotide drugs are a class of therapeutic agents composed of short nucleotide sequences […]

Lipid Nanoparticle

Lipid Nanoparticles (LNPs) Design and Formulation Production

Compared with viral vectors, non-viral delivery vectors are easier to scale up and have the ability to solve the most critical safety issues. Thanks to the LNP-mRNA vaccine that came […]

protac

Based on Antibody Targeted Protein Degradation

In recent years, PROteolysis TArgeting Chimeras (PROTAC), which utilizes the cell’s own degradation mechanisms to eliminate specific disease-related proteins, has emerged as one of the most promising methods. Apart from […]

mRNA delivery

mRNA Strategies for Cancer Immunotherapy

Cancer immunotherapy holds enormous potential in combating malignant tumors. Messenger ribonucleic acid (mRNA) has emerged as a widely studied tool in recent years, functioning within the cytoplasm and eliminating the […]

ADCs Targeting Trop2

What are the Possibilities for ADCs Targeting Trop2?

Antibody drug conjugate (ADC) research involves more and more targets, such as HER-2, Trop-2, Claudin-18.2, B7-H3 and B7-H4, etc. Trop-2 is a transmembrane glycoprotein. Its high expression is associated with the […]

siRNA Drug Delivery

siRNA Drug Delivery Across the Blood-brain Barrier in Alzheimer’s Disease

Alzheimer’s disease (AD) is a very common neurodegenerative disease in old age, which not only affects the patient’s thinking, memory and independence, but also leads to a decline in the quality of […]

drug discovery

Prodrug Activation Strategies in Drug Discovery

A prodrug, also known as a precursor drug, generally refers to a class of compounds that are themselves inactive or have weak activity but, after conversion within a biological organism, […]

Differences Between Protein Degraders and Traditional Small Molecule Drugs

Targeted protein degradation (TPD) is an emerging protein degradation technology in recent decades that utilizes the cell’s own protein clearance mechanisms, such as lysosomal degradation and proteasomal degradation, to degrade target […]

Research Progress of Dual-Loading ADCs

Antibody-drug conjugate (ADC) combines the tumor targeting specificity of monoclonal antibodies and the potent cell killing activity of cytotoxic drugs (warhead/payload), through a carefully designed chemical linker (linker). The two are […]

Self-Replicating RNA

Principles and Applications of Self-Replicating RNA Design

The emergence of RNA synthesis in vitro and in vivo delivery methods has garnered significant attention in the biomedical field, particularly regarding the applications of synthetic mRNA. However, in most biological […]